These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16598312)

  • 1. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome.
    Chen CY; Lin LI; Tang JL; Tsay W; Chang HH; Yeh YC; Huang CF; Chiou RJ; Yao M; Ko BS; Chen YC; Lin KH; Lin DT; Tien HF
    Leukemia; 2006 Jun; 20(6):1155-8. PubMed ID: 16598312
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation.
    Suzuki M; Abe A; Kiyoi H; Murata M; Ito Y; Shimada K; Morishita Y; Kinoshita T; Naoe T
    Leukemia; 2006 Jun; 20(6):1168-9. PubMed ID: 16557239
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
    Wang SA; Hasserjian RP; Loew JM; Sechman EV; Jones D; Hao S; Liu Q; Zhao W; Mehdi M; Galili N; Woda B; Raza A
    Leukemia; 2006 Sep; 20(9):1641-4. PubMed ID: 16871284
    [No Abstract]   [Full Text] [Related]  

  • 5. The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.
    Yip SF; So CC; Chan AY; Liu HY; Wan TsK; Chan LC
    Leukemia; 2006 Jun; 20(6):1165. PubMed ID: 16572200
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
    Tartaglia M; Niemeyer CM; Fragale A; Song X; Buechner J; Jung A; Hählen K; Hasle H; Licht JD; Gelb BD
    Nat Genet; 2003 Jun; 34(2):148-50. PubMed ID: 12717436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
    Watkins F; Fidler C; Boultwood J; Wainscoat JS
    Am J Hematol; 2004 Aug; 76(4):417. PubMed ID: 15282682
    [No Abstract]   [Full Text] [Related]  

  • 8. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
    Yamamoto T; Isomura M; Xu Y; Liang J; Yagasaki H; Kamachi Y; Kudo K; Kiyoi H; Naoe T; Kojma S
    Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients.
    Ohyashiki K; Aota Y; Akahane D; Gotoh A; Miyazawa K; Kimura Y; Ohyashiki JH
    Leukemia; 2005 Dec; 19(12):2359-60. PubMed ID: 16239910
    [No Abstract]   [Full Text] [Related]  

  • 10. RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma.
    Sharma MK; Zehnbauer BA; Watson MA; Gutmann DH
    Neurology; 2005 Oct; 65(8):1335-6. PubMed ID: 16247081
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia.
    Goemans BF; Zwaan CM; Martinelli S; Harrell P; de Lange D; Carta C; Reinhardt D; Hählen K; Creutzig U; Tartaglia M; Heinrich MC; Kaspers GJ
    Br J Haematol; 2005 Sep; 130(5):801-3. PubMed ID: 16115145
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
    Christiansen DH; Desta F; Andersen MK; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2007 Jun; 46(6):517-21. PubMed ID: 17330262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
    Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases.
    Kerr B; Delrue MA; Sigaudy S; Perveen R; Marche M; Burgelin I; Stef M; Tang B; Eden OB; O'Sullivan J; De Sandre-Giovannoli A; Reardon W; Brewer C; Bennett C; Quarell O; M'Cann E; Donnai D; Stewart F; Hennekam R; Cavé H; Verloes A; Philip N; Lacombe D; Levy N; Arveiler B; Black G
    J Med Genet; 2006 May; 43(5):401-5. PubMed ID: 16443854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
    Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.
    Desta F; Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Leukemia; 2006 Mar; 20(3):547-8. PubMed ID: 16424876
    [No Abstract]   [Full Text] [Related]  

  • 18. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
    Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
    Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of PTPN11 are rare in adult myeloid malignancies.
    Hugues L; Cavé H; Philippe N; Pereira S; Fenaux P; Preudhomme C
    Haematologica; 2005 Jun; 90(6):853-4. PubMed ID: 15951301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.